ABSTRACT
Using human cyclin D1 as the "bait" in a yeast two-hybrid system, together with a HL60 cDNA library, we identified a novel human nuclear protein designated DIP1. This protein is expressed in a variety of cell types, and in fibroblasts its level remains constant throughout the cell cycle. However, the level of this protein increases severalfold during the differentiation of HL60 cells. The DIP1 protein can be phosphorylated in vitro by a cellular kinase and this activity reaches its maximum in extracts obtained from cells in the G1 phase of the cell cycle. DIP1 contains a helix-loop-helix motif but lacks an adjacent basic DNA-binding domain, thus resembling the Id family of proteins. The dip1 gene is located on human chromosome 16p11.2-12, a locus that is amplified in several types of human cancer. These results suggest that DIP1 may be involved in the control of gene expression and differentiation, but its precise function remains to be determined.
Subject(s)
Drosophila Proteins , Nuclear Proteins/genetics , Repressor Proteins , Transcription Factors/genetics , Amino Acid Sequence , Base Sequence , Cloning, Molecular , Cyclin D1/genetics , DNA, Complementary/genetics , DNA, Complementary/isolation & purification , HL-60 Cells , Helix-Loop-Helix Motifs , Humans , Inhibitor of Differentiation Protein 1 , Molecular Sequence Data , Nuclear Proteins/analysis , Sequence Alignment , Sequence AnalysisABSTRACT
Frequent deletions of the distal region on the long arm of chromosome 6 have been reported in multiple human tumors including B-cell non-Hodgkin lymphoma (B-NHL), suggesting the presence of one or more tumor suppressor genes (TSGs) at this locus. Previously, we identified a region of minimal molecular deletion at 6q25-q27 (RMD-1) in B-NHL cases. To facilitate positional cloning efforts to identify the RMD-1 TSG(s), a yeast artificial chromosome (YAC) contig consisting of 110 clones was constructed across 6q26-q27 by sequence-tagged site/probe content mapping. The contig integrates 79 ordered markers including restriction fragment length polymorphisms, minisatellites, microsatellites, YAC-insert termini, expressed sequence tags, and known genes. It spans 34 cM and has a minimal tiling path of approximately 12 clones, covering an estimated 9-14 Mb with nearly every marker on the map showing at least double linkage to its adjacent markers. Dual-color fluorescence in situ hybridization of selected marker pairs on normal pachytene chromosome 6 further confirmed the YAC-based mappings. Utilizing a loss of constitutional heterozygosity assay in the B-NHL tumor panel, 24 additional 6q26-q27 polymorphic markers (21 mapping to the contig) further defined RMD-1 between markers D6S186 proximally and D6S227 distally. The minimal tiling path of the B-NHL RMD-1 consists of approximately 8 YAC clones, providing a size estimate of 5-9 Mb. This interval contains, in their entirety, several smaller candidate TSG critical regions previously delimited in other tumor systems. The AF-6 gene, mapping within RMD-1, revealed no mutations in a small subset of B-NHL. The deletion and physical maps presented herein provide a framework for the identification of the gene(s) involved in B-NHL as well as other malignancies and diseases mapped to this region and provide the initial reagents for large-scale genomic sequencing.
Subject(s)
Chromosome Deletion , Chromosome Mapping , Chromosomes, Human, Pair 6 , Cloning, Molecular , Lymphoma, B-Cell/genetics , Neoplasms/genetics , Chromosomes, Artificial, Yeast , Electrophoresis, Gel, Pulsed-Field , Genes, Tumor Suppressor/genetics , Humans , In Situ Hybridization, Fluorescence , Kinesins/genetics , Loss of Heterozygosity , Minisatellite Repeats , Molecular Probe Techniques , Mutation , Myosins/genetics , Polymorphism, Restriction Fragment Length , Sequence Tagged SitesABSTRACT
Comparative genomic hybridization serves as a screening test for regions of copy number changes in tumor genomes. We have applied the technique to map DNA gains and losses in 5 cell lines derived from glioblastoma multiforme, the most common primary neoplasm of the central nervous system. The most frequent losses occurred on chromosomes 10 and 13. The most common gains were observed on chromosomes 5, 6, 7 and 20. Some novel sites of genomic alterations were also observed. Analysis of common areas of loss and gain in these cell lines provides a basis for future attempts to more finely map these genetic changes and for elucidation of genes involved in tumor progression.
Subject(s)
Glioblastoma/genetics , Gliosarcoma/genetics , Nucleic Acid Hybridization/methods , Aged , Brain Neoplasms/genetics , Chromosome Deletion , DNA Nucleotidylexotransferase/metabolism , DNA, Neoplasm/analysis , Female , Gene Dosage , Genome, Human , Humans , Male , Metaphase/genetics , Microscopy, Fluorescence , Middle Aged , Signal Processing, Computer-Assisted , Tumor Cells, CulturedABSTRACT
We have assembled a high-resolution physical map of human chromosome 13 DNA (approximately 114 Mb) from hybridization, PCR, and FISH mapping data using a specifically designed set of computer programs. Although the mapping of 13p is limited, 13q (approximately 98 Mb) is covered by an almost continuous contig of 736 YACs aligned to 597 contigs of cosmids. Of a total of 10,789 cosmids initially selected from a chromosome 13-specific cosmid library (16,896 colonies) using inter-Alu PCR probes from the YACs and probes for markers mapped to chromosome 13, 511 were assembled in contigs that were established from cross-hybridization relationships between the cosmids. The 13q YAC-cosmid map was annotated with 655 sequence tagged sites (STSs) with an average spacing of 1 STS per 150 kb. This set of STSs, each identified by a D number and cytogenetic location, includes database markers (198), expressed sequence tags (93), and STSs generated by sequencing of the ends of cosmid inserts (364). Additional annotation has been provided by positioning 197 cosmids mapped by FISH on 13q. The final (comprehensive) map, a list of STS primers, and raw data used in map assembly are available at our Web site (genome1.ccc.columbia.edu/ approximately genome/) and can serve as a resource to facilitate accurate localization of additional markers, provide substrates for sequencing, and assist in the discovery of chromosome 13 genes associated with hereditary diseases.
Subject(s)
Chromosome Mapping/methods , Chromosomes, Human, Pair 13 , Cosmids/genetics , Sequence Tagged Sites , Animals , Chromosomes, Artificial, Yeast , Computer Communication Networks , Cricetinae , Humans , Hybrid Cells , Polymerase Chain Reaction , Repetitive Sequences, Nucleic AcidABSTRACT
The TFDP genes encode a family of transcription factors that can form heterodimers with E2F family proteins in vivo. The E2F-TFDP transcription factors are major regulators of genes that are required for the progression of S-phase, such as DHFR and DNA polymerase alpha, and they play a critical role in cell cycle regulation and differentiation. The retinoblastoma tumor suppressor protein has been shown to induce growth arrest by binding to E2F-TFDP and repressing its activity. Two human TFDP genes have been cloned, namely TFDP1 and TFDP2 (or DP1 and DP2). In the present study, we identified genomic clones of TFDP1, its pseudogene TFDP1P and TFDP2, and we mapped them to chromosome 13q34, 1q32.3, and 3q23, respectively. Chromosomal abnormalities involving regions 13q34 and 3q23 have been reported in certain lymphomas and other diseases associated with loss of cell cycle regulation, and the involvement of the TFDP transcription factors remains to be elucidated.
Subject(s)
Carrier Proteins , Cell Cycle Proteins , Chromosome Mapping , Chromosomes, Human, Pair 13 , Chromosomes, Human, Pair 1 , Chromosomes, Human, Pair 3 , DNA-Binding Proteins/genetics , Multigene Family , Transcription Factors/genetics , Transcription Factors/metabolism , Cloning, Molecular , DNA-Binding Proteins/metabolism , Dimerization , E2F Transcription Factors , Humans , In Situ Hybridization, Fluorescence , Pseudogenes , Retinoblastoma-Binding Protein 1 , Transcription Factor DP1ABSTRACT
Activating mutations in the c-K-ras gene occur in about 40% of human colorectal carcinomas, yet the role of this oncogene in tumorigenesis is not known. We have developed a model cell culture system to study this problem, utilizing the immortalized but non-tumorigenic epithelial cell line IEC18, originally derived from normal rat intestine epithelium. These cells were cotransfected with the drug resistance selectable marker tk-neo and the plasmid pMIKcys, which encodes a mini human c-K-ras gene (15 kb) containing a cysteine mutation at codon 12. Drug resistant clones were isolated. Clones which also expressed the activated c-K-ras gene displayed a transformed morphology, decreased doubling time, increased level of diacylglycerol, anchorage independent growth in soft agar and an aneuploid karyotype and they were also tumorigenic when injected into nude mice. These clones also displayed increased expression, at both the mRNA and protein levels, of cyclin D1 and Rb. These findings may be of clinical relevance since human colorectal tumors also frequently display increased expression of both cyclin D1 and Rb. This model system may be useful for understanding the role and interrelationship between activation of the c-K-ras oncogene and increased expression of cyclin D1 and Rb in colorectal tumorigenesis.
Subject(s)
Colon/metabolism , Cyclins/genetics , Genes, Retinoblastoma , Oncogene Proteins/genetics , Animals , Cell Line, Transformed , Colon/pathology , Colorectal Neoplasms/genetics , Cyclin D1 , Genes, ras , Humans , Karyotyping , Mice , Mice, Nude , RatsABSTRACT
Various types of physical mapping data were assembled by developing a set of computer programs (Integrated Mapping Package) to derive a detailed, annotated map of a 4-Mb region of human chromosome 13 that includes the BRCA2 locus. The final assembly consists of a yeast artificial chromosome (YAC) contig with 42 members spanning the 13q12-13 region and aligned contigs of 399 cosmids established by cross-hybridization between the cosmids, which were selected from a chromosome 13-specific cosmid library using inter-Alu PCR probes from the YACs. The end sequences of 60 cosmids spaced nearly evenly across the map were used to generate sequence-tagged sites (STSs), which were mapped to the YACs by PCR. A contig framework was generated by STS content mapping, and the map was assembled on this scaffold. Additional annotation was provided by 72 expressed sequences and 10 genetic markers that were positioned on the map by hybridization to cosmids.
Subject(s)
Breast Neoplasms/genetics , Chromosome Mapping/methods , Chromosomes, Human, Pair 13/genetics , Neoplasm Proteins/genetics , Software , Transcription Factors/genetics , BRCA2 Protein , Base Sequence , Chromosomes, Artificial, Yeast/genetics , Chromosomes, Human, Pair 13/ultrastructure , Cosmids/genetics , DNA, Complementary/genetics , Disease Susceptibility , Female , Gene Expression , Humans , In Situ Hybridization, Fluorescence , Molecular Sequence Data , Oligonucleotide Probes , Polymerase Chain Reaction , Repetitive Sequences, Nucleic Acid , Selection, GeneticABSTRACT
Patients with Fanconi anemia (FA) have an extraordinary predisposition to acute myelogenous leukemia (AML). The genetic mechanisms underlying the neoplastic transformation of FA hematopoietic cells are unknown. In this study, we have investigated the molecular features of hematopoiesis in the course of FA at different stages of the disease, including aplastic anemia, myelodysplastic syndrome (MDS), and AML. The analysis focused on defining the clonality status of FA hematopoiesis as well as the putative involvement of N-ras, a dominantly acting oncogene, and p53, a tumor suppressor gene, which are known to play a role in human hematopoietic tumors. Clonality of hematopoiesis was assessed by testing X-chromosome inactivation at the DXS255 locus, which displays different methylation patterns according to the activation status of the corresponding X homolog. Five out of seven FA cases analysed for clonality displayed monoclonal hematopoiesis, including one case at the aplastic anemia stage, three cases with MDS and one with AML. Mutations of the N-ras and p53 genes were studied by a combination of single strand conformation polymorphism (SSCP) analysis and direct sequencing of the PCR product in the bone marrow and/or peripheral blood of 18 FA patients (seven with aplastic anemia, seven with MDS, four with AML). Only normal N-ras and p53 sequences were detected in all cases analyzed. These results suggest that monoclonal hematopoiesis is a frequent finding in the course of FA and may precede the onset of neoplasia in some cases. The genetic mechanisms underlying FA-associated leukemogenesis appear to be independent of N-ras and p53 mutations, which are relatively frequent events in myeloid tumors associated with other hematologic disorders.
Subject(s)
Fanconi Anemia/genetics , Genes, p53 , Genes, ras , Hematopoiesis , Hematopoietic Stem Cells/pathology , Leukemia, Myeloid, Acute/genetics , Mutation , Myelodysplastic Syndromes/genetics , Base Sequence , Bone Marrow/pathology , Clone Cells , Exons , Fanconi Anemia/blood , Fanconi Anemia/pathology , Female , Humans , Leukemia, Myeloid, Acute/blood , Leukemia, Myeloid, Acute/pathology , Male , Myelodysplastic Syndromes/blood , Myelodysplastic Syndromes/pathology , Polymerase Chain Reaction , Polymorphism, Genetic , Reference ValuesABSTRACT
Metabolic gradients are known to influence cellular differentiation at critical junctures of development. The existence of these gradients will stimulate variations in the rate of generation of active oxygen metabolites by metabolic pathways. Recent evidence suggests that cellular oxidation can induce changes in gene expression during normal development. Conversely, antioxidants such as ascorbate, alpha-tocopherol and beta-carotene are inhibitory to differentiation in many types of cells. One basis of oxidative influence on gene expression stems from changes in cellular calcium distribution.
Subject(s)
Antioxidants , Growth , Oxygen/metabolism , Animals , Cell Differentiation , Lipid PeroxidationABSTRACT
Fanconi anemia is a rare autosomal recessive disorder in which affected individuals are predisposed to acute myelogenous leukemia and other malignancies. We report the results of a genetic linkage study involving 34 families enrolled in the International Fanconi Anemia Registry. A significant lod score was obtained between D20S20, an anonymous DNA segment from chromosome 20q, and Fanconi anemia (Zmax 3.04, theta max = 0.12). However, six other anonymous DNA segments from chromosome 20q, including D20S19, which is highly polymorphic and tightly linked to D20S20, showed no or only weak evidence for linkage to Fanconi anemia. An admixture test revealed significant evidence for linkage heterogeneity (chi 2 = 6.10, P = 0.01) at the D20S19 locus. Lod scores suggestive of linkage between Fanconi anemia and this locus were obtained with two of the largest kindreds studied (lods = 2.6 and 2.1, at theta = 0.001). Thus, our data support the provisional assignment of a Fanconi anemia gene to chromosome 20q.
Subject(s)
Chromosomes, Human, Pair 20 , Fanconi Anemia/genetics , Genetic Linkage , Chromosome Mapping , Female , Genetic Markers/genetics , Humans , Lod Score , Male , PedigreeABSTRACT
A literature survey has been conducted to estimate the incidence of breakpoints in aborters. Out of 9,012 cases that could be evaluated, about 4.0% had chromosomal abnormalities, which is significantly higher as compared to the normal population (1-0.5%). The structural anomalies were 7 times higher than numerical abnormalities. Thirty-seven percent of the rearrangements were in males while 63.0% were in females. Among all types of chromosomal aberrations, the Robertsonian types were most frequent (22.3%). However, no sex chromosomal abnormalities were found. Furthermore, the breakpoints on each chromosome were cumulated and no relationship with the relative length of chromosomes was observed. Nevertheless, 60.3% of the breakpoints were localized in G-negative areas of the human genome. The currently known heritable fragile sites were further correlated with the incidence of breakpoints in aborters. A significant relationship with heritable fragile sites was found in this study. Therefore, a family study including the abortus is suggested to establish the mode of inheritance, which possibly could be autosomal recessive. This approach in turn will provide new information to geneticists for counselling the subjects with recurrent fetal loss.